Stockreport

Annovis Announces Two Presentations at the CTAD 2025 Conference

Annovis Bio, Inc.  (ANVS) 
PDF MALVERN, Pa., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering tra [Read more]